Voting Results of 33rd Annual General Meeting - September 26, 2026

Medicamen Biotech Ltd. has announced the voting results of its 33rd Annual General Meeting (AGM) held on September 26, 2026. The meeting was conducted through two-way Video Conferencing (VQ) facility / Other Audio-Visual Means ('OAVM'). The voting results show that all resolutions were passed with 100% approval from the shareholders. The resolutions include the adoption of the audited standalone financial statements for the financial year ended March 31, 2026, the adoption of the audited consolidated financial statements for the financial year ended March 31, 2026, and the re-appointment of Mr. Suresh Kumar Singh as a director liable to retire by rotation.